Nagano Satoshi, Yokouchi Masahiro, Nagayoshi Ryusaku, Sasaki Hiromi, Shimada Hirofumi, Setoguchi Takao, Ijiri Kosei, Komiya Setsuro
Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
J Orthop Surg (Hong Kong). 2013 Dec;21(3):375-9. doi: 10.1177/230949901302100323.
Paget disease of bone (PDB) is a bone metabolic disorder causing pain, fractures, and deformity. Its incidence is estimated to be 1 to 2% in Caucasians older than 55 years, but in Asian populations the incidence is rare. We report on 2 female and one male Japanese patients aged 46 to 73 years with PDB. One patient had monostotic disease with pain around the shoulder and the other 2 were asymptomatic. All patients had elevated alkaline phosphatase (ALP) levels (range, 629-957 U/L). Two patients responded to oral bisphosphonate treatment and achieved normalised ALP levels and pain relief. One patient with polyostotic disease did not show any change in ALP levels. The diagnosis of the disease and the indications for bisphosphonate treatment are discussed.
骨佩吉特病(PDB)是一种骨代谢紊乱疾病,可导致疼痛、骨折和畸形。据估计,55岁以上的白种人中该病的发病率为1%至2%,但在亚洲人群中发病率较低。我们报告了3例年龄在46至73岁之间的日本PDB患者,其中2例为女性,1例为男性。1例患者为单骨型疾病,肩部周围疼痛,另外2例无症状。所有患者的碱性磷酸酶(ALP)水平均升高(范围为629 - 957 U/L)。2例患者接受口服双膦酸盐治疗后,ALP水平恢复正常且疼痛缓解。1例多骨型疾病患者的ALP水平未出现任何变化。本文对该病的诊断及双膦酸盐治疗的适应证进行了讨论。